Tourniquet effect on rocuronium use during lower extremity fracture fixation - Scorecard - MDSpire

Tourniquet effect on rocuronium use during lower extremity fracture fixation

  • By

  • Madeline M. Lyons

  • Carlo Eikani

  • Robert Burnham

  • Adam Schiff

  • Michael Ander

  • Ashley E. Levack

  • Joseph Cohen

  • February 20, 2026

  • 0 min

Share

Clinical Scorecard: Impact of Tourniquet Application on Rocuronium Administration in Lower Limb Fracture Surgery

At a Glance

CategoryDetail
ConditionNeuromuscular blockade monitoring during lower limb fracture surgery with tourniquet use
Key MechanismsTourniquet inflation restricts blood flow, prolonging rocuronium effect distal to the tourniquet and affecting neuromuscular blockade monitoring accuracy
Target PopulationAdult patients undergoing operative fixation of ankle, tibial plafond, talus, or calcaneus fractures
Care SettingOperating room during general anesthesia with tourniquet application

Key Highlights

  • Tourniquet inflation prolongs rocuronium-induced paralysis distal to the tourniquet by restricting drug clearance.
  • Facial nerve monitoring (proximal to tourniquet) may not accurately reflect neuromuscular blockade status in the operative extremity.
  • Rocuronium re-dosing based on facial nerve twitch response during tourniquet inflation is unnecessary and ineffectual.

Guideline-Based Recommendations

Diagnosis

  • Use peripheral nerve stimulator monitoring at both proximal (facial nerve) and distal (common peroneal nerve) sites to assess neuromuscular blockade.

Management

  • Administer rocuronium prior to tourniquet inflation to achieve muscle relaxation.
  • Avoid re-dosing rocuronium during tourniquet inflation based on facial nerve twitch monitoring.

Monitoring & Follow-up

  • Monitor train-of-four twitches at the facial nerve and common peroneal nerve to assess depth and recovery of paralysis.
  • Recognize that twitch recovery distal to the tourniquet is delayed until tourniquet deflation.

Risks

  • Potential misinterpretation of neuromuscular blockade depth if relying solely on proximal nerve monitoring during tourniquet use.

Patient & Prescribing Data

25 adult patients (mean age 38.8 years, BMI 29.9) undergoing lower limb fracture fixation with tourniquet use

Single dose of rocuronium (1 mg/kg ideal body weight) administered prior to tourniquet inflation; no re-dosing required during surgery despite facial nerve twitch recovery.

Clinical Best Practices

  • Place neuromuscular monitoring leads both proximal (facial nerve) and distal (common peroneal nerve) to the tourniquet.
  • Confirm complete muscle relaxation (0 twitches) at both sites before tourniquet inflation.
  • Interpret twitch recovery distal to the tourniquet with caution, understanding delayed return until tourniquet deflation.
  • Coordinate monitoring responsibilities between anesthesia (facial nerve) and surgical teams (operative extremity).
  • Maintain adherence to study protocol for neuromuscular monitoring to ensure accurate assessment.

References

Original Source(s)

Related Content